Clinical Context: The Phase 2 trial by Metabolic Pharmaceuticals found significant fat loss at 1mg (1,000mcg)/day over 12 weeks compared to placebo
CPT Code Injection Administration-Handling highly complex infusion billing internally frequently overwhelms clinical staff and leads to massive operational inefficiencies
Thiamine (B1), Riboflavin (B2), Niacinamide (B3), Panthenol (B5), and Pyridoxal (B6) supports the detoxification of steroid hormones, such as estrogens, as well as organic compounds and heavy metals, such as arsenic
Supporting cancer therapy Studies show that NNMT can affect cancer development and growth
Research suggests BPC-157 has a favorable safety profile in clinical studies, though individual responses may vary